Top 10 Most Expensive Chronic Diseases in the US
Chronic diseases and their expensive treatments are the most important factors driving soaring healthcare expenditures in the global healthcare industry.…
Global B2B Marketplace for Supplier Selection, Vendor Selection
Global B2B Marketplace for Supplier Selection, Vendor Selection
Chronic diseases and their expensive treatments are the most important factors driving soaring healthcare expenditures in the global healthcare industry.…
Oncology drugs is one of the fastest-growing segments in the global pharmaceutical industry. Over the next five years, oncology drug…
The newest of Novartis’s聽cancer drugs, Kisqali, has received European Union approval. Kisqali will be used as a first-line treatment for…
With cancer rates on the rise, oncology drugs are more valuable and necessary now than ever before. For pharmaceutical companies,…
Cancer will soon become the leading cause of death in Canada. A new report by the Canadian Cancer Society (CCS)…